Diabetes Care Devices - Iran

  • Iran
  • Revenue in the Diabetes Care Devices market market in Iran is projected to reach US$97.76m in 2024.
  • Revenue in Iran is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 10.77%, culminating in a market volume of US$163.00m by 2029.
  • In a global context, the majority of revenue will be generated the United States, which is estimated to reach US$11,710.00m in 2024.
  • In Iran, the diabetes care devices market is experiencing a notable shift towards innovative solutions, driven by increasing awareness of diabetes management and healthcare accessibility.

Key regions: Netherlands, Japan, France, Italy, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diabetes Care Devices Market in Iran is witnessing considerable growth, fueled by factors such as increasing prevalence of diabetes, advancements in technology, greater health awareness, and the demand for more efficient monitoring solutions among patients.

Customer preferences:
In Iran, there is a notable shift towards personalized diabetes management solutions, as consumers increasingly favor devices that offer real-time monitoring and data integration with mobile applications. This trend is influenced by a growing emphasis on self-care and proactive health management, particularly among younger demographics who are more tech-savvy. Additionally, the cultural focus on family health has led to increased support for diabetes education, enhancing the appeal of comprehensive care devices that involve family members in the management process.

Trends in the market:
In Iran, the Diabetes Care Devices Market is experiencing a significant transition towards integrated digital solutions. The adoption of continuous glucose monitoring (CGM) systems is on the rise, as users seek devices that provide real-time data and seamless connectivity with smartphones. This shift is fueled by a heightened awareness of diabetes management among the youth, who prioritize technology in health decisions. Furthermore, educational initiatives centered on diabetes are gaining momentum, fostering community engagement and support. These trends signify a pivotal opportunity for industry stakeholders to innovate and cater to a more informed and health-conscious consumer base.

Local special circumstances:
In Iran, the Diabetes Care Devices Market is uniquely influenced by cultural attitudes towards health and wellness, alongside a strong emphasis on traditional dietary practices. The community's increasing acceptance of modern medical technology, combined with government efforts to improve healthcare infrastructure, is fostering a supportive environment for diabetes management solutions. Additionally, regulatory frameworks are evolving, allowing for greater market entry of innovative devices. These local factors are creating a dynamic landscape where health education and technology converge, enhancing patient engagement and adherence to diabetes care.

Underlying macroeconomic factors:
The Diabetes Care Devices Market in Iran is significantly shaped by macroeconomic factors such as national economic stability, healthcare funding, and the global economic environment. With a focus on enhancing healthcare infrastructure, the Iranian government is allocating resources to support diabetes management initiatives, which encourages investment in innovative technologies. Furthermore, global trends such as rising diabetes prevalence and advances in medical technology are influencing local market dynamics. Economic sanctions and fluctuations in oil prices also impact fiscal policies, affecting the availability and affordability of diabetes care devices, ultimately shaping market performance and accessibility for patients.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)